Perrigo (PRGO) EBT (QoQ) (2013 - 2026)
Perrigo (PRGO) EBT (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Perrigo | 1.93 Bn | 1.54 Bn | 313.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 125.80% |
| Mar 28, 2026 | 69.32% |
| Dec 31, 2025 | -6,045.09% |
| Sep 27, 2025 | 600.00% |
| Jun 28, 2025 | -61.45% |
| Mar 29, 2025 | -88.14% |
| Dec 31, 2024 | 221.10% |
| Sep 28, 2024 | 129.46% |
| Jun 29, 2024 | 24.95% |
| Mar 30, 2024 | -81.58% |
| Dec 31, 2023 | -382.81% |
| Sep 30, 2023 | -14.67% |
| Jul 1, 2023 | 423.26% |
| Apr 1, 2023 | 130.07% |
| Dec 31, 2022 | -308.57% |
| Oct 1, 2022 | 96.77% |
| Jul 2, 2022 | -733.08% |
| Apr 2, 2022 | -231.31% |
| Dec 31, 2021 | -97.45% |
| Oct 2, 2021 | 347.55% |